Literature DB >> 1191314

Reduction in binding of [14C] aflatoxin B1 to rat liver macromolecules by phenobarbitone pretreatment.

R C Garner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1191314     DOI: 10.1016/0006-2952(75)90039-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

Review 1.  Metabolism of a prototype mycotoxin, aflatoxin B1, and its genetic regulation.

Authors:  H L Gurtoo; R Dahms; J B Vaught
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

2.  Mutagenicity of aflatoxin B1, activated by S-9 fractions of human, rat, mouse, rabbit, and monkey liver, towards S. typhimurium TA 98.

Authors:  K Norpoth; R Grossmeier; H Bösenberg; H Themann; M Fleischer
Journal:  Int Arch Occup Environ Health       Date:  1979-01-15       Impact factor: 3.015

3.  Modification of DNA by aflatoxin B1 creates alkali-labile lesions in DNA at positions of guanine and adenine.

Authors:  A D D'Andrea; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  Covalent binding of aflatoxin B1 to liver DNA in rats pretreated with ethanol.

Authors:  M Marinovich; W K Lutz
Journal:  Experientia       Date:  1985-10-15

5.  Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver.

Authors:  T Shimada; F P Guengerich
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  The effect of aflatoxins on the incorporation of RNA and protein precursors by isolated hepatocytes.

Authors:  P R McIntosh; I H Evans; B R Rabin
Journal:  Br J Cancer       Date:  1976-04       Impact factor: 7.640

7.  Further study of alpha benzene hexachloride inhibition of aflatoxin B1 hepatocarcinogenesis in rats.

Authors:  S Angsubhakorn; N Bhamarapravati; K Romruen; S Sahaphong; W Thamavit; M Miyamoto
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.